Syapse drives healthcare transformation through precision medicine, enabling provider systems to improve clinical outcomes, streamline operations, and shift to new payment models. Syapse Precision Medicine Platform is a comprehensive software suite used by leading health systems to support the clinical implementation of precision medicine in oncology and other service lines. This category-defining platform enables clinical and genomic data integration, decision support, care coordination, and quality improvement at point of care.

Company Growth (employees)
Palo Alto, US
Size (employees)
129 (est)+4%
Syapse was founded in 2008 and is headquartered in Palo Alto, US

Syapse Office Locations

Syapse has offices in Palo Alto, Philadelphia and San Francisco
Palo Alto, US (HQ)
230 101 University Ave

Syapse Financials and Metrics

Summary Metrics

Syapse's latest funding round in November 2017 was reported to be $30 m. In total, Syapse has raised $69.6 m

Syapse's Web-traffic and Trends

Syapse Online and Social Media Presence

Syapse News and Updates

VC-backed Syapse hires oncology VP

San Francisco-based Syapse, a provider of precision medicine solutions, has named Dr. Aradhana Ghosh as vice president of oncology. Ghosh is a former medical oncologist at IBM Watson Health. Syapse's backers include Social Capital, Safeguard Scientifics, Ascension Ventures, GE Ventures, Intermountai…

Syapse Company Life and Culture

You may also be interested in